FROM PUBLIC EVENTS · 2026-11-15

Current stage

  1. Discovery · preclinical
  2. Early clinical · first deals
  3. Late clinical · capacity
  4. Commercial · sales
  1. Global approvals · expansion
  2. M&A · integration
  3. Pipeline reshaping

Global approvals · expansion Began entering Latin America with Mexican approval for a molecular diagnostic product.

  • Mexican product approval for its HPV molecular diagnostic product. Source

Roles often seen at this stageRegulatory affairs · Sales & marketing · Research & development

Companies at the same stage and their people flow →

← Company library
Korea / Company briefSources checked 2026-11-15

HLB Panagene

A company using PNA (peptide nucleic acid) technology for cancer and infectious-disease molecular diagnostics, also researching PNA-based therapeutics.

PANA RealTyper HPV Kit

Approved

HPV molecular diagnostic kit approved in Mexico as a Class II in-vitro diagnostic device.

PNA oligonucleotides

Technology platform

PNA synthesis platform used for diagnostic products and therapeutic research.

Completion reported

Its HPV molecular diagnostic product was approved in Mexico.

Official role guide

HLB Panagene careers

Current availability unconfirmed

Observed 2026-11-15

Work
Unconfirmed — The official careers page could not be confirmed.
Experience & requirements
Unconfirmed — The official careers page could not be confirmed.

Information from a role guide does not establish a current vacancy.

Sources & coverage 2

A brief based on selected official material, not an exhaustive product or vacancy list.

  1. HLB파나진, HPV 분자진단 제품 멕시코 품목허가…중남미 공략 ↗뉴스1 · Published 2026-11-11 · Sources checked 2026-11-15 · Original unavailable
  2. HLB파나진, 'OTS 2026'서 PNA 화학적 변형 연구 성과 발표 ↗파이낸셜뉴스 · Published 2026-09-29 · Sources checked 2026-11-15 · Original unavailable